CDKN2A and neurodegenerative disease: P16 accumulation, which correlates with other makers of senescence, has been shown to increase as early as 4 months of age in hippocampus of the MAPT P301S PS19 mouse model of tau-dependent neurodegenerative disease (Bussian et al., 2018).